test

Miran Ahmad

@Samsara Biocapital, Llc

Latest period2024 - Q3ReportedManaged Assets$520.277MTotal holdings42
Assets growth rate8.9%Assets growth rate (2-Q avg)-8.59%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Samsara Biocapital, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 42 positions.

Assets under management

The assets under management (AUM) of Samsara Biocapital, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 520.277M in assets, with a quarterly growth rate of 8.9% and a 2-quarter average growth rate of -8.59%. The portfolio is managed by Miran Ahmad, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
ACLXArcellx Inc
Recent Activity
Decreased -22.04%
5.68%
$29.533M
353,641 shares@ $83.52 avg price
CLYMEliem Therapeutics Inc
Recent Activity
Decreased -20%
2.56%
$13.28M
2.609M shares@ $5.09 avg price
CTNMContineum Therapeutics Inc
Recent Activity
Decreased 0%
2.17%
$11.27M
588,816 shares@ $19.14 avg price
VRNAVerona Pharma Plc
Recent Activity
Decreased -43.82%
1.08%
$5.617M
195,225 shares@ $28.77 avg price
DAWNDay One Biopharmaceuticals I
Recent Activity
Decreased -24.99%
0.4%
$2.052M
147,319 shares@ $13.94 avg price
JANXJanux Therapeutics Inc
Recent Activity
Decreased -50%
0.2%
$1.023M
22,526 shares@ $45.43 avg price